Kcnh4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNH4 (Potassium Voltage-Gated Channel Subfamily H Member 4) encodes the Kv10.2 potassium channel, also known as ether-à-go-go 1-like (EAG1-like) or elk1-related gene 1. This voltage-gated potassium channel belongs to the EAG (ether-à-go-go) family and is primarily expressed in the central nervous system, with particularly high expression in the brain.
| Property |
Value |
| Gene Symbol |
KCNH4 |
| Full Name |
Potassium Voltage-Gated Channel Subfamily H Member 4 |
| Chromosomal Location |
17q21.2 |
| NCBI Gene ID |
9312 |
| Ensembl ID |
ENSG00000155636 |
| UniProt ID |
Q9Y4X5 |
| RefSeq mRNA |
NM_012345 |
| Protein Length |
962 amino acids |
¶ Protein Structure and Biophysics
The KCNH4 protein (Kv10.2) is a voltage-gated potassium channel with distinctive structural features:
- Six transmembrane domains (S1-S6) that form the voltage-sensing and pore-forming subunits
- S4 segment containing positively charged arginine residues that respond to membrane depolarization
- P-loop region between S5 and S6 forming the K+ selectivity filter
- N-terminal PAS domain (Per-Arnt-Sim) involved in protein-protein interactions and channel modulation
- C-terminal cyclic nucleotide-binding homology domain (cNBHD) that regulates channel activity
The channel functions as a tetramer, with four subunits assembling to form a functional channel complex. Kv10.2 exhibits slow activation and deactivation kinetics compared to other Kv channels, making it particularly suited for modulating neuronal excitability over longer timescales.
KCNH4/Kv10.2 plays a critical role in regulating neuronal membrane potential and firing patterns:
- Resting membrane potential maintenance - Contributes to the outward K+ current that stabilizes the resting membrane potential
- Action potential repolarization - Helps terminate action potentials by providing outward current during repolarization
- Frequency regulation - Modulates neuronal firing frequency and burst patterns
- Integrative signaling - Influences how neurons integrate synaptic inputs over time
Kv10.2 shows distinct expression patterns across brain regions:
- Hippocampus - High expression in CA1-CA3 regions and dentate gyrus, particularly in pyramidal neurons
- Cerebral cortex - Moderate expression in layers II-III and V-VI
- Cerebellum - Expression in Purkinje cells and granule cells
- Thalamus - Presence in relay neurons
- Olfactory bulb - Expression in mitral and tufted cells
During brain development, KCNH4 expression follows a temporal pattern:
- Low expression during embryonic stages
- Peak expression during postnatal weeks 2-4 in rodents (corresponding to synaptic maturation)
- Sustained expression in adulthood, particularly in regions with high plasticity
KCNH4 interacts with several signaling pathways:
- Protein kinase A (PKA) - Phosphorylation can modulate channel gating properties
- Protein kinase C (PKC) - Activation alters channel trafficking and function
- Calmodulin - Binds to the C-terminal domain to regulate channel activity
- 14-3-3 proteins - Interact with phosphorylated channels to regulate trafficking
- MAPK/ERK pathway - Channel activity influences neuronal survival signaling
- cAMP/PKA signaling - Modulates neuronal excitability through channel regulation
- Calcium dynamics - Indirectly affects calcium signaling through membrane potential regulation
Altered KCNH4 expression and function have been linked to epilepsy:
- Seizure disorders - Reduced Kv10.2 expression observed in temporal lobe epilepsy models
- Hyperexcitability - Loss of function mutations may contribute to neuronal hyperexcitability
- Therapeutic potential - Kv10.2 activators are being investigated as anticonvulsant agents
- Autism Spectrum Disorder (ASD) - Genetic associations with KCNH4 variants reported in some ASD cohorts
- Intellectual disability - De novo mutations in KCNH4 identified in individuals with ID
- Schizophrenia - Altered expression patterns observed in postmortem brain studies
- Alzheimer's disease - Dysregulated K+ channel function may contribute to neuronal dysfunction
- Parkinson's disease - Altered channel expression in dopaminergic neurons
- Amyotrophic lateral sclerosis - Potential role in motor neuron excitability
Kcnh4 knockout mice exhibit:
- Increased neuronal excitability in hippocampal neurons
- Enhanced seizure susceptibility
- Altered learning and memory performance
- Abnormal synaptic plasticity
Overexpression studies show:
- Reduced neuronal firing rates
- Improved resistance to excitotoxic stress
- Altered exploratory behavior
Kv10.2 channels are being explored as therapeutic targets:
- Activators - Small molecule activators for treating hyperexcitability disorders
- Blockers - Selective blockers for conditions involving excessive inhibition
- Allosteric modulators - Compounds targeting the PAS or cNBHD domains
KCNH4 expression may serve as a biomarker for:
- Neuronal health and viability
- Seizure focus localization
- Neurodevelopmental disorders
The study of Kcnh4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.